Orphan receptor

Examples

Examples of orphan receptors are found in the G protein-coupled receptor (GPCR) and nuclear receptor families.

If an endogenous ligand is found, the orphan receptor is "adopted" or "de-orphanized". An example is the nuclear receptor farnesoid X receptor (FXR) and TGR5/GPCR19/G protein-coupled bile acid receptor, both of which are activated by bile acids. Adopted orphan receptors in the nuclear receptor group include FXR, liver X receptor (LXR), and peroxisome proliferator-activated receptor (PPAR). Another example of an orphan receptor site is the PCP binding site in the NMDA receptor, a type of ligand-gated ion channel. This site is where the recreational drug PCP works, but no endogenous ligand is known to bind to this site.

GPCR orphan receptors are usually given the name "GPR" followed by a number, for example GPR21. In the GPCR family, nearly 100 receptor-like genes remain orphans.

Discovery

Historically, receptors were discovered by using ligands to "fish" for their receptors. Hence, by definition, these receptors were not orphans. However, with modern molecular biology techniques such as reverse pharmacology, screening of cDNA libraries, and whole genome sequencing, receptors have been identified based on sequence similarity to known receptors, without knowing what their ligands are.

References

References

1. (2015-01-01). "ONRLDB—manually curated database of experimentally validated ligands for orphan nuclear receptors: insights into new drug discovery". Database.
2. (2006). "Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers". EMBO Rep.
3. (2006). "Orphan GPCRs and their ligands". Pharmacol Ther.
4. (2004). "The identification of ligands at orphan G-protein coupled receptors". Annu Rev Pharmacol Toxicol.
5. Giguère V. (October 1999). "Orphan nuclear receptors: from gene to function". Endocr. Rev..
6. (2006). "International Union of Pharmacology. LXVI. Orphan nuclear receptors". Pharmacol Rev.
7. Shi Y. (June 2007). "Orphan Nuclear Receptors in Drug Discovery". Drug Discov. Today.
8. SHI, Y. (2007). "Orphan nuclear receptors in drug discovery". Drug Discovery Today.
9. (April 2003). "Structural basis for bile acid binding and activation of the nuclear receptor FXR". Mol. Cell.
10. Fagg GE. (May 1987). "Phencyclidine and related drugs bind to the activated N-methyl-D-aspartate receptor-channel complex in rat brain membranes". Neurosci. Lett..
11. (2018). "The G protein-coupled receptors deorphanization landscape". Biochemical Pharmacology.